1 – 34 of 34
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
(
- Contribution to journal › Article
- 2022
-
Mark
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
(
- Contribution to journal › Article
-
Mark
Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
(
- Contribution to journal › Article
-
Mark
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives
(
- Contribution to journal › Article
-
Mark
The human melanoma proteome atlas-Defining the molecular pathology
(
- Contribution to journal › Article
-
Mark
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
(
- Contribution to journal › Article
-
Mark
Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
An observational study on the molecular profiling of primary melanomas reveals a progression dependence on mitochondrial activation
(
- Contribution to journal › Article
- 2020
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
(
- Contribution to journal › Article
-
Mark
Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
-
Mark
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
- 2017
-
Mark
Limited tumor tissue drug penetration contributes to primary resistance against angiogenesis inhibitors
(
- Contribution to journal › Article
- 2015
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
-
Mark
Association of Chromosome 19 to Lung Cancer Genotypes and Phenotypes
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Aptamer/ISET-MS: A New Affinity-Based MALDI Technique for Improved Detection of Biomarkers
(
- Contribution to journal › Article
- 2013
-
Mark
Stardardization Developments for Large Scale Biobanks in Smoking Related Diseases - A Model System for Blood Sample Processing and Storage
(
- Contribution to journal › Article
-
Mark
Chromosome 19 Annotations with Disease Speciation - A First Report from the Global Research Consortium
(
- Contribution to journal › Article
-
Mark
Developments in Biobanking Workflow Standardization Providing Samples Integrity and Stability
(
- Contribution to journal › Scientific review
-
Mark
Identification of a Novel Proteoform of Prostate Specific Antigen (SNP-L132I) in Clinical Samples by Multiple Reaction Monitoring.
(
- Contribution to journal › Article
- 2012
-
Mark
Large Scale Biobanking of Blood – The Importance of High Density Sample Processing Procedures
(
- Contribution to journal › Article
-
Mark
Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.
(
- Contribution to journal › Article
- 2011
-
Mark
Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples
(
- Contribution to journal › Article
- 2010
-
Mark
Identification of prostate specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
(
- Contribution to journal › Article
-
Mark
Characterization of PSA in clinical samples by mass spectrometry
2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.508-510(
- Contribution to journal › Published meeting abstract
-
Mark
Mass spectrometric strategy for clearcut identification of prostate specific antigen in clinical Samples
2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.114-117(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of PSA in clinical samples by mass spectrometry
2010) Swedish Proteomics Society Symposium, 2010(
- Contribution to conference › Abstract
- 2009
-
Mark
Multiplex approach for identification of PSA variants in clinical samples
(
- Contribution to journal › Published meeting abstract